Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05363267 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NF-1, Nutraceutical Intervention

StatusActive, Not Recruiting
PhasePhase 1
Started2022-07-06
View on ClinicalTrials.gov ↗

Amendment history

2026-09-24
Completion pushed: 2026-08 → 2027-08
2026-05-29
2 amendments v6-v7
2 re-verifications since 2026-01-09, no change to tracked fields
2025-09-03
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v5
Trial statusRecruiting→Active, Not Recruiting
Primary completion dateestimated 2025-08→confirmed 2025-09-02
Enrollment targetestimated 18→confirmed 23
Study sitesdetails revised at 1 of 1 site
2024-09-09
Study Status v4
Primary completion date2024-08→2025-08
Completion date2025-08→2026-08
2024-05-15
Study Status v3
Re-verified, no change to tracked fields
Show 2 earlier versions
2023-08-25
Study Status v2
Primary completion date2023-08→2024-08
Completion date2024-08→2025-08
2022-08-23
Not Yet Recruiting→Recruiting Study Status, Outcome Measures, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2022-07→confirmed 2022-07-06
Study sites0→1
2022-04-29
Original filing
The treatment plan is identical for all participants with the exception of the curcumin dose level that is assigned at study enrollment. Participants are instructed to take the curcumin and olive oil one after the other (order does not matter) twice a day on an empty stomach ideally 30 minutes before breakfast and dinner. Curcumin and high phenolic extra virgin olive oil (HP-EVOO) may continue for up to 12 months in the absence of unacceptable side effects.
Trial Details
NCT Number NCT05363267
Lead Sponsor Masonic Cancer Center, University of Minnesota
Conditions Neurofibromatosis 1
Enrollment 23 participants
Start Date 2022-07-06
Primary Completion 2025-09-02 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-09-23